31.18 USD
▲+2.39+2.60%
盘后 29.79 -1.97%
2026-08-03
市值
$952.53M
市盈率
—
EPS
-0.65
股息率
—
52 周区间
14.59 – 44.28
成交量
675.29K
Beta
0.97
目标价
44.00
52W 低 14.5952W 高 44.28
价格走势
公司简介
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasi...